TherapeuticsMD Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
/ 
Frequently asked questions
To buy TherapeuticsMD Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for TherapeuticsMD Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for TherapeuticsMD Inc. is TXMD:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
TherapeuticsMD Inc. has its primary listing on NASDAQ. You can trade TherapeuticsMD Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, TherapeuticsMD Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include TherapeuticsMD Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like TherapeuticsMD Inc..